日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan

血管紧张素II 1型受体信号传导促进膀胱癌进展,而氯沙坦可抑制该信号传导。

Yamanaka, Ryoken; Miura, Kento; Yamasaki, Norimasa; Ogata, Sawako; Nakamura, Megmi; Inaba, Toshiya; Bold-Erdene, Anarkhuu; Enkhbaatar, Uyanga; Mirkatouli, Fatemeh Beygom; Miura, Shuka; Hosomi, Naohisa; Kobatake, Kohei; Takemoto, Kenshiro; Kohada, Yuki; Tasaka, Ryo; Hatayama, Tomoya; Yukihiro, Kazuma; Shikuma, Hiroyuki; Iwane, Kyosuke; Hinata, Nobuyuki; Kaminuma, Osamu

KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma

KIFC1与透明细胞肾细胞癌的肉瘤样分化、免疫反应和不良预后相关

Nakano, Yoshinori; Sekino, Yohei; Kobayashi, Go; Nakahara, Hikaru; Akabane, Shintaro; Takemoto, Kenshiro; Naito, Miki; Miyamoto, Shunsuke; Kobatake, Kohei; Kitano, Hiroyuki; Goto, Keisuke; Goriki, Akihiro; Hieda, Keisuke; Hinoi, Takao; Hinata, Nobuyuki

TROP2 expression is associated with early stage and favorable prognosis in upper tract urothelial carcinoma

TROP2表达与上尿路尿路上皮癌的早期阶段和良好预后相关

Kobayashi, Go; Sekino, Yohei; Hayashi, Tetsutaro; Nakahara, Hikaru; Kobatake, Kohei; Kitano, Hiroyuki; Goto, Keisuke; Niitsu, Hiroaki; Hinoi, Takao; Sentani, Kazuhiro; Hinata, Nobuyuki

Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after ureteral stent removal following radical cystectomy

根治性膀胱切除术后取出输尿管支架后,采用尿培养指导的抗生素预防可降低发热性肾盂肾炎的发生率。

Kitano, Hiroyuki; Watanabe, Eisuke; Tadera, Kayoko; Nakano, Yoshinori; Tasaka, Shinsaku; Yukihiro, Kazuma; Okazaki, Mai; Nomura, Naofumi; Hatayama, Tomoya; Shikuma, Hiroyuki; Iwane, Kyosuke; Tasaka, Ryo; Kohada, Yuki; Takemoto, Kenshiro; Miyamoto, Shunsuke; Naito, Miki; Kobatake, Kohei; Sekino, Yohei; Goto, Keisuke; Goriki, Akihiro; Hieda, Keisuke; Hayashi, Tetsutaro; Kashiyama, Seiya; Ohge, Hiroki; Hinata, Nobuyuki

Intraoperative real-time display of 3D reconstruction models in robot-assisted partial nephrectomy

机器人辅助部分肾切除术中三维重建模型的术中实时显示

Miyamoto, Shunsuke; Shikuma, Hiroyuki; Tasaka, Ryo; Kohada, Yuki; Takemoto, Kenshiro; Naito, Miki; Kobatake, Kohei; Sekino, Yohei; Kitano, Hiroyuki; Ikeda, Kenichiro; Goto, Keisuke; Goriki, Akihiro; Hieda, Keisuke; Hayashi, Tetsutaro; Hinata, Nobuyuki

Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis

吸烟对前列腺癌治疗结果的基因组和临床影响:一项公共数据库分析

Hatayama, Tomoya; Sekino, Yohei; Kobayashi, Go; Yukihiro, Kazuma; Nakano, Yoshinori; Tasaka, Shinsaku; Nomura, Naofumi; Kohada, Yuki; Takemoto, Kenshiro; Naito, Miki; Miyamoto, Shunsuke; Kobatake, Kohei; Kitano, Hiroyuki; Goto, Keisuke; Goriki, Akihiro; Hieda, Keisuke; Hinata, Nobuyuki

Real-World Effectiveness and Safety of Pembrolizumab-Lenvatinib Versus Axitinib-Based Regimens in Metastatic Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Study

帕博利珠单抗联合乐伐替尼与阿昔替尼方案治疗转移性透明细胞肾细胞癌的真实世界疗效和安全性:一项多中心回顾性研究

Kobatake, Kohei; Goto, Keisuke; Fujita, Akira; Babasaki, Takashi; Ueno, Takeshi; Kurimura, Yoshimasa; Fukuoka, Kenichiro; Kirishima, Fumiaki; Nishida, Kensuke; Hayashi, Tetsutaro; Hinata, Nobuyuki

Author Correction: JMJD3-mediated senescence is required to overcome stress-induced hematopoietic defects

作者更正:JMJD3介导的衰老是克服应激诱导的造血缺陷所必需的。

Nakata, Yuichiro; Ueda, Takeshi; Sera, Yasuyuki; Koizumi, Miho; Imamura, Katsutoshi; Kanai, Akinori; Ikeda, Ken-Ichiro; Yamasaki, Norimasa; Nagamachi, Akiko; Kobatake, Kohei; Taguchi, Masataka; Sotomaru, Yusuke; Ichinohe, Tatsuo; Honda, Zen-Ichiro; Nakamura, Takuro; Manabe, Ichiro; Suda, Toshio; Takubo, Keiyo; Kaminuma, Osamu; Honda, Hiroaki

The Gender-Biased Differential Effect of KDM6A Mutation on Immune Therapy in Urothelial Carcinoma: A Public Database Study

KDM6A突变对尿路上皮癌免疫治疗的性别差异性影响:一项基于公共数据库的研究

Sekino, Yohei; Nakahara, Hikaru; Ikeda, Kenichiro; Kobatake, Kohei; Kohada, Yuki; Tasaka, Ryo; Takemoto, Kenshiro; Miyamoto, Shunsuke; Kitano, Hiroyuki; Goto, Keisuke; Goriki, Akihiro; Hieda, Keisuke; Hinata, Nobuyuki

KDM6A deficiency promotes tumor progression and resistance to cabozantinib treatment in clear cell renal cell carcinoma.

KDM6A 缺陷会促进透明细胞肾细胞癌的肿瘤进展和对卡博替尼治疗的耐药性。

Kohada Yuki, Kobatake Kohei, Takemoto Kenshiro, Sekino Yohei, Babasaki Takashi, Miura Kento, Yamanaka Ryoken, Nakahara Hikaru, Tasaka Ryo, Fukushima Takafumi, Kitano Hiroyuki, Goto Keisuke, Goriki Akihiro, Hieda Keisuke, Kaminuma Osamu, Hinata Nobuyuki